Amy Lin
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Transplantation top 1%
- Renal Transplantation Outcomes and Treatments
Papers in
- Hepatology 15
- Hepatitis C virus research 15
-
- Renal Transplantation Outcomes and Treatments 4
- Co-authors
- Joseph H. HoffmanStefan ZeuzemJ. RasenackM. DiagoS.V. FeinmanE. Jenny HeathcoteEdward GaneMichael J. Brunda
- Journals
- Journal of Hepatology (4 papers)Journal of Addictive Diseases (3 papers)Transplantation (3 papers)Journal of Medical Virology (2 papers)New England Journal of Medicine (2 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Amy Lin
25 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Hepatology 1.8k
- Transplantation 296
- Epidemiology 1.8k
- Rheumatology 224
- Immunology 192
Countries citing papers authored by Amy Lin
This map shows the geographic impact of Amy Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Lin more than expected).
Fields of papers citing papers by Amy Lin
This network shows the impact of papers produced by Amy Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Lin. The network helps show where Amy Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 9 | |
| 2 | 2020 | 27 | |
| 3 | 2009 | 12 | |
| 4 | Adolescent and Young Adult Heroin Patients | 2008 | 7 |
| 5 | 2008 | 32 | |
| 6 | 2008 | 56 | |
| 7 | 2008 | 1 | |
| 8 | 2008 | 8 | |
| 9 | 2007 | 1 | |
| 10 | 2006 | 23 | |
| 11 | 2006 | 29 | |
| 12 | 2004 | 64 | |
| 13 | 2002 | 25 | |
| 14 | 2002 | 112 | |
| 15 | 2001 | 88 | |
| 16 | 2001 | 20 | |
| 17 | Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis Hit paper breakdown → | 2000 | 682 |
| 18 | Peginterferon Alfa-2a in Patients with Chronic Hepatitis C Hit paper breakdown → | 2000 | 954 |
| 19 | 1999 | 243 | |
| 20 | 1987 | 59 |
About Amy Lin
Amy Lin is a scholar working on Hepatology, Transplantation, Aging, Epidemiology and Rheumatology, having authored 25 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (6 papers), Hepatitis B Virus Studies (6 papers), Renal Transplantation Outcomes and Treatments (4 papers), Systemic Lupus Erythematosus Research (4 papers), Opioid Use Disorder Treatment (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Polyamine Metabolism and Applications (2 papers). The work is most often cited by research in Hepatology (1.8k citations), Transplantation (296 citations), Epidemiology (1.8k citations), Rheumatology (224 citations) and Immunology (192 citations). Amy Lin has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Joseph H. Hoffman, Stefan Zeuzem, J. Rasenack, M. Diago, S.V. Feinman, E. Jenny Heathcote, Edward Gane, Michael J. Brunda, Jürg Reichen and John O’Grady. Their work appears in journals such as Journal of Hepatology, Journal of Addictive Diseases, Transplantation, Journal of Medical Virology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.